91 related articles for article (PubMed ID: 20189709)
21. Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium.
Mulvany NJ; Allen DG
Int J Gynecol Pathol; 2008 Jan; 27(1):49-57. PubMed ID: 18156975
[TBL] [Abstract][Full Text] [Related]
22. Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors.
Sturgeon SR; Sherman ME; Kurman RJ; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Brinton LA
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):231-5. PubMed ID: 9521439
[TBL] [Abstract][Full Text] [Related]
23. Occurrence of endometrial cancer six years after treatment with thermal balloon ablation (Thermachoice): first case report.
Le Marrec A; Lavoue V; Morcel K; Duval H; Bauville E; Foucher F; Leveque J
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):219-20. PubMed ID: 20304551
[No Abstract] [Full Text] [Related]
24. Sister Mary Joseph's nodule: recurrent endometrial adenocarcinoma presenting as an umbilical metastasis.
Sengupta S; Church E; Chia KV
J Obstet Gynaecol; 2009 Feb; 29(2):170-1. PubMed ID: 19274568
[No Abstract] [Full Text] [Related]
25. Maspin expression is up-regulated during the progression of endometrioid endometrial carcinoma.
Tsuji T; Umekita Y; Ohi Y; Kamio M; Douchi T; Yoshida H
Histopathology; 2007 Dec; 51(6):871-4. PubMed ID: 18042077
[No Abstract] [Full Text] [Related]
26. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of hysteroscopic imaging in endometrioid endometrial adenocarcinoma.
Garuti G; De Giorgi O; Sambruni I; Cellani F; Luerti M
Gynecol Oncol; 2001 Jun; 81(3):408-13. PubMed ID: 11371130
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.
Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ
J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331
[TBL] [Abstract][Full Text] [Related]
30. Letter to the editor in response to "Stage 1, grade 3 endometrioid adenocarcinoma of the endometrium: An analysis of clinical outcomes and patterns of recurrence".
Pollock J
Gynecol Oncol; 2010 Jun; 117(3):507; author reply 507-8. PubMed ID: 20189231
[No Abstract] [Full Text] [Related]
31. Rare case of small-cell carcinoma arising from the endometrium with paraneoplastic retinopathy.
Sekiguchi I; Suzuki M; Sato I; Ohkawa T; Kawashima H; Tsuchida S
Gynecol Oncol; 1998 Dec; 71(3):454-7. PubMed ID: 9887249
[TBL] [Abstract][Full Text] [Related]
32. Small-cell carcinoma of the esophagus associated with a paraneoplastic neurological syndrome: a case report documenting a complete response.
Shimoda T; Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Azuma M; Saigenji K; Katou T; Ogino M
Jpn J Clin Oncol; 2006 Feb; 36(2):109-12. PubMed ID: 16517835
[TBL] [Abstract][Full Text] [Related]
33. Spontaneously ruptured endometrioma associated with endometrioid adenocarcinoma: MR findings.
Kozawa E; Matsuo Y; Hasegawa K; Fujiwara K; Sakurai T; Kimura F
Magn Reson Med Sci; 2010; 9(4):233-6. PubMed ID: 21187693
[TBL] [Abstract][Full Text] [Related]
34. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
Lax SF; Kurman RJ
Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874
[TBL] [Abstract][Full Text] [Related]
35. Endometrial adenocarcinoma: an apostasy from early views.
Sivridis E; Giatromanolaki A
Gynecol Oncol; 2004 Dec; 95(3):772-3. PubMed ID: 15582004
[No Abstract] [Full Text] [Related]
36. Ciliated carcinoma of the endometrium associated with mucinous and neuroendocrine differentiation: a case report with immunohistochemical and ultrastructural study.
Motoyama T; Ajioka Y; Ohta T; Watanabe H
Pathol Int; 1994 Jun; 44(6):480-5. PubMed ID: 8055116
[TBL] [Abstract][Full Text] [Related]
37. Life-Threatening Hypercalcemia due to Ectopic Intact Parathyroid Hormone Secretion from a Poorly Differentiated Endometrioid Carcinoma.
Deshaies D; Hariri N; Dyer B; Richmond B
Am Surg; 2019 Jan; 85(1):e45-e46. PubMed ID: 30760371
[No Abstract] [Full Text] [Related]
38. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
[TBL] [Abstract][Full Text] [Related]
39. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.
Guirguis A; Elishaev E; Oh SH; Tseng GC; Zorn K; DeLoia JA
Gynecol Oncol; 2008 Feb; 108(2):370-6. PubMed ID: 18083218
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic factors of stage III endometrial carcinoma].
Li J; Kong WM
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):198-200. PubMed ID: 19537039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
